Skip to main content

Granules shares rise 5% on US FDA nod for ADHD treatment drug

The stock has rallied 86 per cent in the past three months as compared to 13.5 per cent rise in the S&P BSE Sensex

from Home Page https://ift.tt/3iiGRq8

Comments

Popular posts from this blog